Any T-cell-mediated disease benefits from therapy without affecting other inflammatory pathways
ProKidney’s Diabetes and CKD Cell Therapy Rilparencel Improves eGFR Slope Annual Decline in Phase 2 Trial
Alongside the new data from REGEN-007, ProKidney also announced that it will be attending a Type B meeting with the FDA later in the summer.
Cell Therapy in Parkinson Disease: Bemdaneprocel and What Lies Ahead
Mind Moments®, a podcast from our sister site NeurologyLive®, held an exclusive interview with Rajesh Pahwa, MD.
China's NMPA Accepts Satri-Cel NDA for Filing
The NDA is supported primarily by data from the phase 2 CT041-ST-01 randomized controlled clinical trial.
ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP
In Episode 4 of ImmunoLogic, Caroline Diorio, MD, FRCPC, FAAP, discussed her research on adverse events associated with cell therapy.
Cell Therapy’s Lot in Solid Tumors: Challenges and Opportunities
Several experts weighed in on the various strategies being explored to tackle solid tumors with cell therapy, expressing optimism despite the plethora of obstacles that remain.
CGTLive®’s Weekly Rewind – July 4, 2025
Review top news and interview highlights from the week ending July 4, 2025.